comparemela.com
Latest Breaking News On - Pediatric early phase clinical trial network - Page 1 : comparemela.com
GlycoMimetics, Inc. (NASDAQ:GLYC) Q4 2023 Earnings Call Transcript
Operator: Good morning, and thank you for joining the GlycoMimetics Q4 and Full Year 2023 Earnings Call. At this time, all participants are in a listen-only mode.
United-states
American
Tara-bancroft
Christian-dinneen
Bruce-johnson
Brian-hahn
Harout-semerjian
Naureen-quibria
Children-oncology-group-phase
Company-counsel-at-glycomimetics
Glycomimetics-inc
Pediatric-early-phase-clinical-trial-network
GlycoMimetics, Inc. (NASDAQ:GLYC) Q3 2023 Earnings Call Transcript
Operator: Good morning, and thank you for joining the GlycoMimetics Q3 2023 Earnings Call. At this time, all participants are in a listen-only mode.
San-diego
California
United-states
Boston
Massachusetts
Dana-farber-cancer-institute
American
Debora-peralta
Harout-semerjian
Gaetano-bonifacio
John-horan
Christian-dinneen
vimarsana © 2020. All Rights Reserved.